Yang Q, Fu B, Luo D, Wang H, Cao H, Chen X, et al
It can be challenging to enhance blood flow while on your period
During a 48-week phase 2 obesity trial, patients on weekly doses of Retatrutide (8 mg and 12 mg) had average body weight losses of 22.8% and 24.2%, respectively
Before you go ahead with any treatment, always make sure your provider is a registered and qualified healthcare professional
Screening for personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2 is essential, as tirzepatide is contraindicated in these conditions
A patient may lose 20, 40, 60, or more pounds and still have important questions: What happens next